CalciMedica, Common Financials
CALC Stock | 3.09 0.08 2.52% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Debt Equity Ratio | 0.0062 | 0.0065 |
|
| |||||
Current Ratio | 2.46 | 2.59 |
|
|
Investors should never underestimate CalciMedica, Common's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor CalciMedica, Common's cash flow, debt, and profitability to make informed and accurate decisions about investing in CalciMedica, Common Stock.
Net Income |
|
CalciMedica, | Select Account or Indicator |
Understanding current and past CalciMedica, Common Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of CalciMedica, Common's financial statements are interrelated, with each one affecting the others. For example, an increase in CalciMedica, Common's assets may result in an increase in income on the income statement.
Please note, the presentation of CalciMedica, Common's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, CalciMedica, Common's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of CalciMedica, Common's management manipulating its earnings.
CalciMedica, Common Stock Summary
CalciMedica, Common competes with Cracker Barrel, Biglari Holdings, BJs Restaurants, Harmony Gold, and Dennys Corp. CalciMedica, Common is entity of United States. It is traded as Stock on NASDAQ exchange.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
CUSIP | 38942Q103 38942Q202 |
Location | California; U.S.A |
Business Address | 505 Coast Boulevard |
Sector | Biotechnology |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.calcimedica.com |
Phone | 858 952 5500 |
CalciMedica, Common Key Financial Ratios
Return On Equity | -0.84 | ||||
EBITDA | (34.19 M) | ||||
Net Income | (34.36 M) | ||||
Book Value Per Share | 1.42 X | ||||
Market Capitalization | 41.66 M |
CalciMedica, Common Key Balance Sheet Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Total Assets | 101.8M | 69.1M | 39.7M | 12.2M | 11.0M | 10.4M | |
Other Current Liab | 4.5M | 3.5M | 1.7M | 2.5M | 2.3M | 3.1M | |
Net Debt | (33.4M) | (13.4M) | (17.1M) | (5.5M) | (6.4M) | (6.7M) | |
Retained Earnings | (133.4M) | (169.2M) | (204.8M) | (146.1M) | (131.5M) | (138.0M) | |
Accounts Payable | 2.5M | 527K | 2.9M | 1.4M | 1.3M | 1.9M | |
Cash | 33.4M | 13.4M | 17.3M | 5.5M | 5.0M | 4.7M | |
Other Current Assets | 4.2M | 3.4M | 1.0M | 367K | 422.1K | 400.9K | |
Total Liab | 7.0M | 4.1M | 3.7M | 4.0M | 3.6M | 4.9M | |
Total Current Assets | 99.2M | 67.1M | 39.7M | 11.6M | 10.4M | 9.9M | |
Net Invested Capital | 94.8M | 65.0M | 36.0M | 8.2M | 9.4M | 8.9M | |
Net Working Capital | 92.2M | 63.0M | 36.0M | 7.6M | 6.8M | 6.5M |
CalciMedica, Common Key Income Statement Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Operating Income | (29.8M) | (35.9M) | (36.2M) | (21.9M) | (25.2M) | (26.4M) | |
Ebit | (29.8M) | (35.9M) | (7.7M) | (34.2M) | (39.4M) | (41.4M) | |
Research Development | 21.0M | 18.9M | 14.1M | 12.4M | 11.1M | 16.0M | |
Ebitda | (29.4M) | (35.4M) | (7.6M) | (34.2M) | (39.3M) | (41.3M) | |
Income Before Tax | (27.5M) | (35.8M) | (35.6M) | (34.4M) | (30.9M) | (32.5M) | |
Net Income | (27.5M) | (35.8M) | (35.6M) | (34.4M) | (30.9M) | (32.5M) | |
Net Interest Income | 143K | 126K | 575K | (110K) | (99K) | (94.1K) | |
Income Tax Expense | (538K) | (2.0M) | 2.4M | (109.9K) | (126.4K) | (132.7K) |
CalciMedica, Common Key Cash Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Change In Cash | 17.5M | (20.1M) | 3.9M | 4.1M | 3.6M | 2.8M | |
Stock Based Compensation | 1.8M | 5.4M | 1.8M | 12.0M | 13.8M | 14.5M | |
Free Cash Flow | (33.1M) | (32.0M) | (25.1M) | (25.8M) | (29.7M) | (31.2M) | |
Change In Working Capital | (4.6M) | (1.6M) | 1.8M | (267K) | (240.3K) | (228.3K) | |
Begin Period Cash Flow | 15.9M | 33.4M | 13.4M | 1.5M | 1.7M | 1.6M | |
Other Cashflows From Financing Activities | (4.1M) | 695K | (8.6M) | (4.5M) | (4.1M) | (3.9M) | |
Depreciation | 395K | 519K | 338K | 58K | 52.2K | 49.6K | |
Other Non Cash Items | (2.2M) | 58K | 2.5M | 110K | 126.5K | 78.3K | |
Capital Expenditures | 1.0M | 488K | 2.3M | 78K | 70.2K | 66.7K | |
Total Cash From Operating Activities | (32.1M) | (31.5M) | (22.9M) | (25.7M) | (29.6M) | (31.1M) | |
Net Income | (27.5M) | (35.8M) | (35.6M) | (34.4M) | (30.9M) | (32.5M) | |
Total Cash From Financing Activities | 92.2M | 695K | (139K) | 20.9M | 18.8M | 28.1M | |
End Period Cash Flow | 33.4M | 13.4M | 17.3M | 5.5M | 5.0M | 4.7M | |
Investments | (42.6M) | 10.8M | 27.0M | 8.9M | 10.2M | 10.7M | |
Issuance Of Capital Stock | 96.3M | 12.6M | 18K | 25.4M | 22.9M | 30.2M |
CalciMedica, Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CalciMedica, Common's current stock value. Our valuation model uses many indicators to compare CalciMedica, Common value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CalciMedica, Common competition to find correlations between indicators driving CalciMedica, Common's intrinsic value. More Info.CalciMedica, Common Stock is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . At present, CalciMedica, Common's Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CalciMedica, Common's earnings, one of the primary drivers of an investment's value.CalciMedica, Common Stock Systematic Risk
CalciMedica, Common's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. CalciMedica, Common volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on CalciMedica, Common Stock correlated with the market. If Beta is less than 0 CalciMedica, Common generally moves in the opposite direction as compared to the market. If CalciMedica, Common Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one CalciMedica, Common Stock is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of CalciMedica, Common is generally in the same direction as the market. If Beta > 1 CalciMedica, Common moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in CalciMedica, Common Stock are looking for potential investment opportunities by analyzing not only static indicators but also various CalciMedica, Common's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of CalciMedica, Common growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
CalciMedica, Common January 20, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of CalciMedica, Common help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of CalciMedica, Common Stock. We use our internally-developed statistical techniques to arrive at the intrinsic value of CalciMedica, Common Stock based on widely used predictive technical indicators. In general, we focus on analyzing CalciMedica, Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build CalciMedica, Common's daily price indicators and compare them against related drivers.
Information Ratio | (0.05) | |||
Maximum Drawdown | 45.05 | |||
Value At Risk | (6.78) | |||
Potential Upside | 5.24 |
Complementary Tools for CalciMedica, Stock analysis
When running CalciMedica, Common's price analysis, check to measure CalciMedica, Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CalciMedica, Common is operating at the current time. Most of CalciMedica, Common's value examination focuses on studying past and present price action to predict the probability of CalciMedica, Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CalciMedica, Common's price. Additionally, you may evaluate how the addition of CalciMedica, Common to your portfolios can decrease your overall portfolio volatility.
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
CEOs Directory Screen CEOs from public companies around the world | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |